CN105477541A - 一种治疗呼吸道感染的雾化吸入液中药制剂 - Google Patents
一种治疗呼吸道感染的雾化吸入液中药制剂 Download PDFInfo
- Publication number
- CN105477541A CN105477541A CN201510926231.XA CN201510926231A CN105477541A CN 105477541 A CN105477541 A CN 105477541A CN 201510926231 A CN201510926231 A CN 201510926231A CN 105477541 A CN105477541 A CN 105477541A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- herba
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 239000007788 liquid Substances 0.000 title claims abstract description 19
- 206010057190 Respiratory tract infections Diseases 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 241000628997 Flos Species 0.000 claims abstract description 30
- 229910052957 realgar Inorganic materials 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 241000195474 Sargassum Species 0.000 claims abstract description 9
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000341 volatile oil Substances 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 26
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 15
- 230000009471 action Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000141218 Alpinia officinarum Species 0.000 abstract 1
- 241000271307 Aquilaria malaccensis Species 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 241001310717 Daphne genkwa Species 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 241000434018 Euphorbia pekinensis Species 0.000 abstract 1
- 241001643730 Hydrangea sect. Dichroa Species 0.000 abstract 1
- 240000004980 Rheum officinale Species 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000032846 Zanthoxylum bungeanum Species 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 230000000410 anti-febrile effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 30
- 239000008280 blood Substances 0.000 description 29
- 208000002193 Pain Diseases 0.000 description 23
- 230000036407 pain Effects 0.000 description 23
- 210000004185 liver Anatomy 0.000 description 22
- 230000001276 controlling effect Effects 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 17
- 229940079593 drug Drugs 0.000 description 16
- 206010047700 Vomiting Diseases 0.000 description 15
- 230000002401 inhibitory effect Effects 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 206010062717 Increased upper airway secretion Diseases 0.000 description 14
- 208000026435 phlegm Diseases 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 230000008673 vomiting Effects 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 208000004880 Polyuria Diseases 0.000 description 12
- 230000035619 diuresis Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- -1 lignanoids Chemical class 0.000 description 12
- 206010010774 Constipation Diseases 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 11
- 238000010792 warming Methods 0.000 description 11
- 208000032843 Hemorrhage Diseases 0.000 description 10
- 230000001717 pathogenic effect Effects 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 230000036772 blood pressure Effects 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 208000006673 asthma Diseases 0.000 description 8
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 230000002147 killing effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 7
- 208000001780 epistaxis Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 230000014759 maintenance of location Effects 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 244000045947 parasite Species 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000001603 reducing effect Effects 0.000 description 6
- 208000011580 syndromic disease Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 5
- 208000034507 Haematemesis Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000001754 anti-pyretic effect Effects 0.000 description 5
- 239000002221 antipyretic Substances 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- RDWWRPSMRUBPHK-DLBZAZTESA-N (6as,11br)-9-methoxy-7,11b-dihydro-6h-indeno[2,1-c]chromene-3,6a,10-triol Chemical compound C1OC2=CC(O)=CC=C2[C@@H]2[C@@]1(O)CC1=C2C=C(O)C(OC)=C1 RDWWRPSMRUBPHK-DLBZAZTESA-N 0.000 description 4
- YRAQEMCYCSSHJG-NSHDSACASA-N (S)-columbianetin Chemical compound C1=CC(=O)OC2=C1C=CC1=C2C[C@@H](C(C)(O)C)O1 YRAQEMCYCSSHJG-NSHDSACASA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010016807 Fluid retention Diseases 0.000 description 4
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- NYRXUBDGDSRBGB-UHFFFAOYSA-N Obtusifolin Chemical compound O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(C)C(O)=C2OC NYRXUBDGDSRBGB-UHFFFAOYSA-N 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- RGCKGOZRHPZPFP-UHFFFAOYSA-N alizarin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 4
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 4
- 150000004056 anthraquinones Chemical class 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000002439 hemostatic effect Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- UEHVFWBKXUSZEQ-UHFFFAOYSA-N orixine Natural products C1=C2C(OC)=C(CC(O)C(C)(C)O)C(OC)=NC2=C2OCOC2=C1 UEHVFWBKXUSZEQ-UHFFFAOYSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 241001480043 Arthrodermataceae Species 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 206010010726 Conjunctival oedema Diseases 0.000 description 3
- FWVHWDSCPKXMDB-LSDHHAIUSA-N Febrifugine Chemical compound O[C@@H]1CCCN[C@H]1CC(=O)CN1C(=O)C2=CC=CC=C2N=C1 FWVHWDSCPKXMDB-LSDHHAIUSA-N 0.000 description 3
- UIHLDYLKWIWXAH-UHFFFAOYSA-N Febrifugine Natural products OC1CCNCC1CC(=O)CN2C=Nc3ccccc3C2=O UIHLDYLKWIWXAH-UHFFFAOYSA-N 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 3
- 208000031361 Hiccup Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 3
- 241001597008 Nomeidae Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 230000001088 anti-asthma Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000002155 anti-virotic effect Effects 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 230000037304 dermatophytes Effects 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- 206010013023 diphtheria Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- FWVHWDSCPKXMDB-UHFFFAOYSA-N febrifugine dihydrochloride Natural products OC1CCCNC1CC(=O)CN1C(=O)C2=CC=CC=C2N=C1 FWVHWDSCPKXMDB-UHFFFAOYSA-N 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- RDWWRPSMRUBPHK-UHFFFAOYSA-N (6aS,11bR)-9-methoxy-3,6a,10-trihydroxy-6a,11b-dihydro-7H-indeno<2,1-c>chromene <3'-O-methylbrazilin> Natural products C1OC2=CC(O)=CC=C2C2C1(O)CC1=C2C=C(O)C(OC)=C1 RDWWRPSMRUBPHK-UHFFFAOYSA-N 0.000 description 2
- OQIOHYHRGZNZCW-UHFFFAOYSA-N 2-methyl-5-propan-2-ylbenzene-1,4-diol Chemical compound CC(C)C1=CC(O)=C(C)C=C1O OQIOHYHRGZNZCW-UHFFFAOYSA-N 0.000 description 2
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 2
- OKBGEROEGQDLFK-UHFFFAOYSA-N 3-(2-hydroxypropan-2-yl)-6-methylspiro[4.5]dec-9-ene-10-carbaldehyde Chemical compound CC1CCC=C(C=O)C11CC(C(C)(C)O)CC1 OKBGEROEGQDLFK-UHFFFAOYSA-N 0.000 description 2
- OIGWAXDAPKFNCQ-UHFFFAOYSA-N 4-isopropylbenzyl alcohol Chemical compound CC(C)C1=CC=C(CO)C=C1 OIGWAXDAPKFNCQ-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 241000588832 Bordetella pertussis Species 0.000 description 2
- SBVZTBIAKFTNIJ-CZNQJBLBSA-N Cassiaside Chemical compound C1=CC=C2C=C3OC(C)=CC(=O)C3=C(O)C2=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SBVZTBIAKFTNIJ-CZNQJBLBSA-N 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- 239000005792 Geraniol Substances 0.000 description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- ZCHGCYXNSBHAEG-UHFFFAOYSA-N Obtusifolin Natural products COc1ccc2C=C(C(=O)Oc2c1C=CC(=C)C)C(C)(C)C=C ZCHGCYXNSBHAEG-UHFFFAOYSA-N 0.000 description 2
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 2
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 2
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 2
- 206010033971 Paratyphoid fever Diseases 0.000 description 2
- 206010034960 Photophobia Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- YRAQEMCYCSSHJG-UHFFFAOYSA-N Tetrahydro-oroselol Natural products C1=CC(=O)OC2=C1C=CC1=C2CC(C(C)(O)C)O1 YRAQEMCYCSSHJG-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000000924 antiasthmatic agent Substances 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000003434 antitussive agent Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 description 2
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- OXLQCHMJDJSJKF-UHFFFAOYSA-N cassiaside Natural products C1=C(O)C=C2C=C3OC(C)=CC(=O)C3=C(O)C2=C1OC1OC(CO)C(O)C(O)C1O OXLQCHMJDJSJKF-UHFFFAOYSA-N 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229940066493 expectorants Drugs 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229940113087 geraniol Drugs 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 230000002443 hepatoprotective effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CNNRPFQICPFDPO-UHFFFAOYSA-N octacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCO CNNRPFQICPFDPO-UHFFFAOYSA-N 0.000 description 2
- NUJGJRNETVAIRJ-UHFFFAOYSA-N octanal Chemical compound CCCCCCCC=O NUJGJRNETVAIRJ-UHFFFAOYSA-N 0.000 description 2
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 2
- 238000010422 painting Methods 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 2
- XOKSLPVRUOBDEW-UHFFFAOYSA-N pinane Chemical compound CC1CCC2C(C)(C)C1C2 XOKSLPVRUOBDEW-UHFFFAOYSA-N 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001543 purgative effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 208000010540 rapid respiration Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 235000021286 stilbenes Nutrition 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- HGXBRUKMWQGOIE-AFHBHXEDSA-N (+)-pinoresinol Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O)=CC=3)CO2)=C1 HGXBRUKMWQGOIE-AFHBHXEDSA-N 0.000 description 1
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 1
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- WHUDNFJAKJGKBT-LOIXOFCESA-N (3r)-3-(2-hydroxypropan-2-yl)-6-methylspiro[4.5]dec-9-ene-10-carboxylic acid Chemical group CC1CCC=C(C(O)=O)C11C[C@H](C(C)(C)O)CC1 WHUDNFJAKJGKBT-LOIXOFCESA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- 229960002666 1-octacosanol Drugs 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- KQLDYIIDXBUUCK-UHFFFAOYSA-N 2,3-dimethylchromen-4-one Chemical compound C1=CC=C2C(=O)C(C)=C(C)OC2=C1 KQLDYIIDXBUUCK-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- MLYYOHQNXPDGGV-UHFFFAOYSA-N 3,5-dimethoxy-2-phenylchromen-4-one Chemical compound COC=1C(=O)C=2C(OC)=CC=CC=2OC=1C1=CC=CC=C1 MLYYOHQNXPDGGV-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- NSRKPHLHEMCETL-UHFFFAOYSA-N 5-(2-phenylethenyl)benzene-1,2,3,4-tetrol Chemical compound OC1=C(O)C(O)=CC(C=CC=2C=CC=CC=2)=C1O NSRKPHLHEMCETL-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- ICWHTQRTTHCUHW-NFAWXSAZSA-N Agarospirol Chemical compound C[C@@H]1CCC=C(C)[C@]11C[C@H](C(C)(C)O)CC1 ICWHTQRTTHCUHW-NFAWXSAZSA-N 0.000 description 1
- ICWHTQRTTHCUHW-UHFFFAOYSA-N Agarospirol Natural products CC1CCC=C(C)C11CC(C(C)(C)O)CC1 ICWHTQRTTHCUHW-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- WHUDNFJAKJGKBT-UHFFFAOYSA-N Baimuxinic acid Natural products CC1CCC=C(C(O)=O)C11CC(C(C)(C)O)CC1 WHUDNFJAKJGKBT-UHFFFAOYSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000033386 Buerger disease Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 description 1
- 240000002495 Cucumis melo var. inodorus Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- MBYXEBXZARTUSS-QLWBXOBMSA-N Emetamine Natural products O(C)c1c(OC)cc2c(c(C[C@@H]3[C@H](CC)CN4[C@H](c5c(cc(OC)c(OC)c5)CC4)C3)ncc2)c1 MBYXEBXZARTUSS-QLWBXOBMSA-N 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- OPUFDNZTKHPZHM-UHFFFAOYSA-N Euparin Chemical compound CC(=O)C1=C(O)C=C2OC(C(=C)C)=CC2=C1 OPUFDNZTKHPZHM-UHFFFAOYSA-N 0.000 description 1
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 1
- KFFCKOBAHMGTMW-LGQRSHAYSA-N Forsythin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)[C@@H]2CO1 KFFCKOBAHMGTMW-LGQRSHAYSA-N 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 206010048612 Hydrothorax Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- RNKZFOIQKCQOAQ-UHFFFAOYSA-N Isopimpinellin Natural products COC1CC(=O)Oc2c(OC)c3occc3cc12 RNKZFOIQKCQOAQ-UHFFFAOYSA-N 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- CMUNUTVVOOHQPW-LURJTMIESA-N L-proline betaine Chemical compound C[N+]1(C)CCC[C@H]1C([O-])=O CMUNUTVVOOHQPW-LURJTMIESA-N 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- DUXQKCCELUKXOE-UHFFFAOYSA-N Pectolinarigenin-Biosid Natural products C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(C)O2)O)O1 DUXQKCCELUKXOE-UHFFFAOYSA-N 0.000 description 1
- SEXCCMQJDXQBOE-UHFFFAOYSA-N Pectolinarin Natural products C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2OC1C(O)C(O)C(OC2C(C(O)C(O)C(C)O2)O)C(CO)O1 SEXCCMQJDXQBOE-UHFFFAOYSA-N 0.000 description 1
- JJVGFDTWFVSBIM-UHFFFAOYSA-N Phillyrin Natural products COc1ccc(cc1OC)C2OCC3C2COC3c4ccc(OC)c(OC5OC(CO)C(O)C(O)C5O)c4 JJVGFDTWFVSBIM-UHFFFAOYSA-N 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUVVAXYIELKVAI-UHFFFAOYSA-N SJ000285215 Natural products N1CCC2=CC(OC)=C(OC)C=C2C1CC1CC2C3=CC(OC)=C(OC)C=C3CCN2CC1CC AUVVAXYIELKVAI-UHFFFAOYSA-N 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241001300766 Stillingia sylvatica Species 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical class C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043540 Thromboangiitis obliterans Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010043866 Tinea capitis Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- KGEKLUUHTZCSIP-HOSYDEDBSA-N [(1s,4s,6r)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl] acetate Chemical compound C1C[C@]2(C)[C@H](OC(=O)C)C[C@H]1C2(C)C KGEKLUUHTZCSIP-HOSYDEDBSA-N 0.000 description 1
- LAISNASYKAIAIK-UHFFFAOYSA-N [S].[As] Chemical compound [S].[As] LAISNASYKAIAIK-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- ZLQADKTVJQXDIG-UHFFFAOYSA-N alpha-Agarofuran Natural products C1CC(C2)C(C)(C)OC22C(C)=CCCC21C ZLQADKTVJQXDIG-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 229940098421 anthraquinone glycoside Drugs 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- BPYGTFFYYOWDBC-LOVSFRALSA-N arctiin Natural products COc1ccc(C[C@H]2COC(=O)[C@@H]2Cc3ccc(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c3)cc1OC BPYGTFFYYOWDBC-LOVSFRALSA-N 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- FIVPIPIDMRVLAY-UHFFFAOYSA-N aspergillin Natural products C1C2=CC=CC(O)C2N2C1(SS1)C(=O)N(C)C1(CO)C2=O FIVPIPIDMRVLAY-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- OKBGEROEGQDLFK-JMSVASOKSA-N baimuxinal Natural products C[C@@H]1CCC=C(C=O)[C@]12CC[C@H](C2)C(C)(C)O OKBGEROEGQDLFK-JMSVASOKSA-N 0.000 description 1
- XWTXUKLVEPDOQT-UHFFFAOYSA-N beta-Agarofuran Natural products C1CC2(C)CCCC(=C)C22OC(C)(C)C1C2 XWTXUKLVEPDOQT-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000002021 butanolic extract Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 125000002871 cinnamic aldehydes group Chemical group 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- DQISGWRLCDLKJI-UHFFFAOYSA-N columbianetin Natural products C1=CC(=O)OC2=C(C(C(C(C)(O)C)O3)O)C3=CC=C21 DQISGWRLCDLKJI-UHFFFAOYSA-N 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000001891 dimethoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- AUVVAXYIELKVAI-CKBKHPSWSA-N emetine Chemical compound N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@@H]1CC AUVVAXYIELKVAI-CKBKHPSWSA-N 0.000 description 1
- 229960002694 emetine Drugs 0.000 description 1
- AUVVAXYIELKVAI-UWBTVBNJSA-N emetine Natural products N1CCC2=CC(OC)=C(OC)C=C2[C@H]1C[C@H]1C[C@H]2C3=CC(OC)=C(OC)C=C3CCN2C[C@H]1CC AUVVAXYIELKVAI-UWBTVBNJSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- BUMHLZPAQKNDBJ-JTQLQIEISA-N euparin Natural products CC=C[C@H]1Cc2cc(C(=O)C)c(O)cc2O1 BUMHLZPAQKNDBJ-JTQLQIEISA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- FIVPIPIDMRVLAY-RBJBARPLSA-N gliotoxin Chemical compound C1C2=CC=C[C@H](O)[C@H]2N2[C@]1(SS1)C(=O)N(C)[C@@]1(CO)C2=O FIVPIPIDMRVLAY-RBJBARPLSA-N 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 231100000546 inhibition of ovulation Toxicity 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- DFMAXQKDIGCMTL-UHFFFAOYSA-N isopimpinellin Chemical compound O1C(=O)C=CC2=C1C(OC)=C1OC=CC1=C2OC DFMAXQKDIGCMTL-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000002664 nootropic agent Substances 0.000 description 1
- 230000001777 nootropic effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000002919 oxepanes Chemical class 0.000 description 1
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 1
- DUXQKCCELUKXOE-CBBZIXHGSA-N pectolinarin Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C(OC)=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 DUXQKCCELUKXOE-CBBZIXHGSA-N 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229930006728 pinane Natural products 0.000 description 1
- OHOPKHNWLCMLSW-UHFFFAOYSA-N pinoresinol Natural products C1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(CO)C(O)=CC=3)CO2)=C1 OHOPKHNWLCMLSW-UHFFFAOYSA-N 0.000 description 1
- 235000007221 pinoresinol Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- CMUNUTVVOOHQPW-ZCFIWIBFSA-N stachydrine Natural products C[N+]1(C)CCC[C@@H]1C([O-])=O CMUNUTVVOOHQPW-ZCFIWIBFSA-N 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- GKAJCVFOJGXVIA-DXKBKAGUSA-N trans-rhaponticin Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C1=CC(O)=CC(O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1 GKAJCVFOJGXVIA-DXKBKAGUSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 230000003191 uterotonic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 206010047470 viral myocarditis Diseases 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- BURBOJZOZGMMQF-UHFFFAOYSA-N xanthoxylol Natural products C1=C(O)C(OC)=CC=C1C1C(COC2C=3C=C4OCOC4=CC=3)C2CO1 BURBOJZOZGMMQF-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- ZLQADKTVJQXDIG-NWANDNLSSA-N α-agarofuran Chemical compound C1C[C@@H](C2)C(C)(C)O[C@@]22C(C)=CCC[C@@]21C ZLQADKTVJQXDIG-NWANDNLSSA-N 0.000 description 1
- IEZDOTGOEOFYHV-AODWJNRKSA-N β-agarofuran Chemical compound C1CC2(C)CCC=C[C@]22OC(C)(C)[C@H]1C2 IEZDOTGOEOFYHV-AODWJNRKSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/234—Cnidium (snowparsley)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药应用领域,特别公开了一种治疗呼吸道感染的雾化吸入液中药制剂。该一种治疗呼吸道感染的雾化吸入液中药制剂,由知母、连翘、大黄、大戟、芫花、丹皮、地丁、枇杷叶、茜草、艾叶、侧柏叶、茵陈、良姜、沉香、海藻、雄黄、麻黄、桂枝、防风、菊花、常山、佩兰、石苇、桑寄生、蛇床子、何首乌、丁香、苏木、决明子、高良姜、花椒、大蓟、黄芪、莪术按照一定的重量配比采用现代先进的医药制药技术制成,本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,具有杀菌能力强,作用速度快,稳定性好的显著优点,对人无刺激,无毒副作用,是一种值得推广的理想的抗菌消炎药物。
Description
(一)技术领域
本发明涉及中药应用领域,特别涉及一种治疗呼吸道感染的雾化吸入液中药制剂。
(二)背景技术
呼吸道感染分为上呼吸道感染与下呼吸道感染。上呼吸道感染是指自鼻腔至喉部之间的急性炎症的总称,是最常见的感染性疾病。下呼吸道感染是最常见的感染性疾患,治疗时必须明确引起感染的病原体以选择有效的抗生素。
传统中医理论:反复呼吸道感染的根本原因在体虚、正气不足、表虚不固,属体虚易感风邪者,当邪气(外界病毒、细菌)入侵时,体内的正气不足以抵御外界邪气,便使抗病能力降低,因此出现一系列反复发作的感染病症。
现代西医理论:据儿科专家最新的观点,反复呼吸道感染的病因与细菌病毒感染尽管有关联,但导致反复发作的根本内因其实是人体的免疫功能紊乱。
目前临床上经常使用地塞米松、庆大霉素和玻璃酸酶用于雾化吸入,对于一般性肺炎效果尚可,喘憋性肺炎患儿由于存在明显通气障碍,吸入药量受限,效果相对较差。现有技术中滥用西药抗生素治疗的现象屡禁不止,中药有很多带有抗菌消炎作用的药物,却没有得到有效的组合利用。
(三)发明内容
本发明为了弥补现有技术的不足,提供了一种制备简单、疗效显著的一种治疗呼吸道感染的雾化吸入液中药制剂。
本发明是通过如下技术方案实现的:
一种治疗呼吸道感染的雾化吸入液中药制剂,制成所述药物有效成分的原料组成及重量份数为:知母10-25克、连翘11-26克、大黄10-23克、大戟10-22克、芫花10-23克、丹皮10-21克、地丁10-23克、枇杷叶10-26克、茜草10-25克、艾叶10-24克、侧柏叶10-26克、茵陈10-25克、良姜10-23克、沉香10-22克、海藻10-23克、雄黄10-25克、麻黄10-22克、桂枝10-26克、防风10-25克、菊花10-23克、常山10-22克、佩兰10-22克、石苇10-23克、桑寄生10-22克、蛇床子10-25克、何首乌10-23克、丁香10-22克、苏木10-23克、决明子10-25克、高良姜10-22克、花椒10-23克、大蓟10-24克、黄芪10-23克、莪术10-25克。
制成所述药物有效成分的原料组成及重量份数为:知母10克、连翘11克、大黄10克、大戟10克、芫花10克、丹皮10克、地丁10克、枇杷叶10克、茜草10克、艾叶10克、侧柏叶10克、茵陈10克、良姜10克、沉香10克、海藻10克、雄黄10克、麻黄10克、桂枝10克、防风10克、菊花10克、常山10克、佩兰10克、石苇10克、桑寄生10克、蛇床子10克、何首乌10克、丁香10克、苏木10克、决明子10克、高良姜10克、花椒10克、大蓟10克、黄芪10克、莪术10克。
制作步骤:
(1)将莪术、大蓟、高良姜、何首乌、桂枝以水蒸气蒸馏提取挥发油,并收集药渣混合备用;
(2)将余药和步骤1中所得药渣混匀加5倍水量,加水煎煮2次,每次50min,合并煎液,静置;然后往煎液中加入3~4倍药液的95%的乙醇,静置15分钟,然后以3000rpm/min离心20分钟,取上清液,喷雾干燥,得出初料;
(3)将步骤1中所得挥发油喷入步骤2所得初料中,混匀,粉碎,过100目筛,密封、灭菌处理,贴签,分装而成。
本发明所用中药的药性如下:
知母:性寒,味苦、甘。归肺经、胃经、肾经。清热泻火、生津润燥。属清热药下属分类的清热泻火药。用治外感热病、高热烦渴、肺热燥咳、骨蒸潮热、内热消渴、肠燥便秘。
连翘:性微寒,味苦。归肺经、心经、小肠经。清热解毒、消肿散结。属清热药下属分类的清热解毒药。用治痈疽、瘰疬、乳痈、丹毒、风热感冒、温病初起、温热入营、高热烦渴、神昏发斑、热淋尿闭。含木脂素类、黄酮类、挥发性成分、苯乙烷类、乙基环己醇类、三萜类及香豆素类等化合物。其中桦木酸、连翘苷、牛蒡子苷、罗汉松脂苷、松脂素、连翘醇苷C、连翘醇苷D等具重要的抗菌和抗病毒作用。主要功能有:抑菌、抗病毒、抗炎、解热、保肝、强心利尿、止呕、降压和维生素的作用。
大黄:性寒,味苦。归脾经、胃经、大肠经、肝经、心包经。泻热通便、凉血解毒、逐瘀通经。属泻下药下属分类的攻下药。用治实热便秘、积滞腹痛、泻痢不爽、湿热黄疸、血热吐衄、目赤、咽肿、肠痈疔疮、瘀血经闭、跌打损伤。泻下成分为结合性蒽醌苷类,抑菌成分为游离性蒽醌。大黄不含土大黄苷,可作为鉴别正、伪品的依据之一。动物实验表明,提取物有泻下、抑菌、止血、促进胆汁分泌、降脂、降压和抗肿瘤作用。
大戟:性寒,味苦。归肺经、脾经、肾经。泻水饮、利二便。属泻下药下分类的峻下逐水药。应用治疗慢性肾炎水肿、水臌、痰饮、瘰疬、痈疽肿毒。内服:煎汤,用量2~5克;或人丸散。外用适量,煎水熏洗。大戟根乙醚抽出物有致泻作用,热水抽出物对猫有剧泻作用。根皮70%乙醇提取液注射于动物,血压轻微上升,肾容积显著缩小,无论剂量大小,利尿作用均不显著。健康成人服煎剂亦无明显利尿作用。提取液对末梢血管有扩张作用,能抑制肾上腺素的升压作用。东北的大戟(Euphorbiasp.)鲜叶汁在试管内对金黄色葡萄球菌及绿脓杆菌有抑制作用,但除去鞣质后,抗菌作用即消失,制剂保存数天或加热亦可使抗菌作用减弱甚至丧失。
芫花:泻水逐饮;祛痰止咳;解毒杀虫。水肿;膨胀;痰饮胸水;喘咳;痈疖疮癣。芫花杀虫治疮。以芫花为末,油调外敷,治疗小儿头癣、头疮。可用该品研末外涂,或配雄黄、猪脂调涂。芫花泻水逐饮。为峻猛的逐水药,长于胸胁之水,多用于治疗胸水。多与甘遂、大戟、大枣等配伍。该品苦寒沉降,泻水之力虽较大戟、甘遂缓和,但仍不失为逐水峻剂,惟水肿、痰饮属实证者方可服用。
丹皮:味辛苦,性凉;归心、肝、肾、肺经。清热;活血散瘀。主温热病热入血分;发斑;吐衄;热泪盈眶病菌后期热伏阴分发热;阴虚骨蒸潮热;血滞经闭;痛经;痈肿疮毒;跌扑伤痛;风湿热痹。
地丁:性味:苦,寒.清热解毒。治疔疮痈肿,黄疸内热,小儿鼻血,阑尾炎,毒蛇咬伤。
枇杷叶:味苦,性微寒。归肺经、胃经。用治肺热咳嗽、气逆喘急、胃热呕逆、烦热口渴。润肺下气止咳逆,宜蜜汁炒用;和胃下气止呕逆,宜姜汁炒用。清肺止咳、降逆止呕。属化痰止咳平喘药下属中的止咳平喘药,临床上试用治肾炎水肿、痤疮等。水煎剂或醋酸乙酯提取物具有祛痰和平喘作用,挥发油有轻度祛痰作用。此外,皂苷也是枇杷叶止咳祛痰的主要成分。醇提物灌胃或局部用药具抗炎作用;乙醚提取物中的三萜成分熊果酸、β-羟基亚油酸甲酯和马斯里酸有抗炎活性。此外,还具抗菌、降血糖、抗肿瘤的作用。
茜草:性寒,味苦。归肝经。凉血、止血、祛瘀、通经。属止血药下分类的凉血止血药。治疗吐血、衄血、崩漏、外伤出血,经闭阏阻、关节痹痛、跌扑肿痛。脾胃虚寒及无瘀滞者忌服。含紫茜素、茜素、茜草色素等成分。小鼠口服根煎剂有明显止咳和祛痰作用,但加酒精沉淀后,滤液即无效;根煎剂能对抗离体兔回肠的收缩作用;根水提物对离体豚鼠子宫有兴奋作用,产妇口服亦有加强子宫收缩的作用;根温浸液能扩张蛙足蹼膜血管,并稍能缩短家兔的血液凝固时间;根在试管内对金黄色与白色葡萄球菌、肺炎球菌及流感杆菌等有一定的抑制作用。
艾叶:性温,味苦、辛。归肝经、脾经、肾经。散寒止痛、温经止血。属止血药下属分类的温经止血药。主要用治少腹冷痛、经寒不调、宫冷不孕、吐血、衄血、崩漏经多、妊娠下血;外治皮肤瘙痒。醋艾炭温经止血。用于虚寒性出血。近年对其药理作用有不少研究,如水浸剂对致病金黄色葡萄球菌及某些皮肤真菌有抑制作用。此外,尚有增进食欲等作用。艾叶油有镇咳、祛痰、平喘、抑菌、镇静、抗休克等作用。
侧柏叶:性寒,味苦、涩。归肺经、肝经、脾经。凉血止血、生发乌发。属止血药下属分类的凉血止血药。用治吐血衄血、咯血、便血、崩漏下血、血热脱发、须发早白。含挥发油、黄酮类化合物和蜡质等成分。药理实验表明,热水提取物1克/千克腹腔注射,对小鼠尾切伤有止血作用。
茵陈:清湿热,退黄疸。用于黄疸尿少,湿疮瘙痒;传染性黄疸型肝炎。
良姜:温中散寒、行气止痛。主治胃脘冷痛,呕吐,嗳气。暖胃散寒,温中止痛。适用于脾胃虚寒,心腹冷痛,呕吐,呃逆,口吐清水,肠鸣腹泻等。
沉香:味辛、苦,性微温。归肾经、脾经、胃经。行气止痛、温中止呕、纳气平喘。属理气药,临床用治寒性胃痛、老年性肠梗阻、便秘、哮喘等。水煎液对离体豚鼠回肠的自主收缩有抑制作用,并能对抗组胺、乙酰胆碱引起的痉挛性收缩。醇提物能促进离体豚鼠气管抗组胺作用,从而发挥止喘效果。此外,具解痉、镇静、镇痛、降压、抗菌的作用。用治胸腹胀闷疼痛、胃寒呕吐呃逆、肾虚气逆喘急。含挥发油及树脂。挥发油中主要成分为白木香酸、白木香醛、α-沉香呋喃、β-沉香呋喃;受曲霉菌感染的沉香挥发油中含沉香螺萜醇、沉香螺萜醛等。
海藻:性寒,味苦、咸。归肝经、胃经、肾经。软坚散结、消痰、利水。属化痰止咳平喘药下属分类的清化热痰药。用治瘿瘤、瘰疬、睾丸肿痛、痰饮水肿。能影响甲状腺功能,有缩肝脾、抑菌、抗凝、降脂和抗肿瘤作用。含藻胶酸、粗蛋白、甘露醇、灰分、脂肪、糖类、粘液质等。此外,提取出一种抗凝血成分,作用类似肝素。
雄黄:解毒杀虫,燥湿祛痰,截疟。属杀虫止痒药。用治痈肿疗疮,蛇虫咬伤,虫积腹痛,惊痫,疟疾。主含硫化砷。尚含铅、锌、镍等16种元素。实验表明,雄黄对金黄色葡萄球菌、绿脓杆菌、多种皮肤真菌和人型、牛型结核杆菌有抑制作用。临床用于治疗带状疱疹、慢性粒细胞型白血病及慢性支气管炎有显著疗效。
麻黄:性温,味辛、微苦。归肺经、膀胱经。发汗散寒、宣肺平喘、利水消肿。属解表药下属分类的辛温解表药。用治风寒感冒、胸闷喘咳、风水浮肿、支气管哮喘。多用治表症已解、气喘咳嗽。含多种生物碱及挥发性盐基苄基甲胺等。其中以麻黄碱为主要有效成分,占总生物碱量的40%~90%,另含大量微量元素。能兴奋中枢神经,还有类似肾上腺素的作用;能抗过敏,对流感病毒有抑制作用;有解热作用;麻黄油乳剂有镇痛作用及引起肌肉瘫痪现象,对蟾蜍心脏有抑制作用;麻黄定碱能降低血压,并有利尿作用。
桂枝:味辛、甘,性温。归膀胱经,心经,肺经。发表解肌、温经通脉、助阳化气、平冲降气,属辛温解表药。实验表明,桂皮醛还有抗惊厥、抗菌、抗病毒、扩张血管和抗炎作用。用治风寒感冒、脘腹冷痛、血寒经闭、关节痹痛、痰饮、水肿、心悸、奔豚。油中主要成分是桂皮醛,为镇静、镇痛、解热作用的有效成分。
防风:性温,味甘、辛。归膀胱经、肝经、脾经,发表、祛风、除湿。属解表药下分类辛温解表药。内服治疗感冒、头痛、发热、无汗、风湿痹痛、四肢拘挛、皮肤风湿瘙痒、破伤风等症。含挥发油,油中有20种化合物,含量较高的有辛醛、β-甜没药烯,人参炔醇(相对含量为82.6%),此外含有色原酮、香豆素、聚乙炔类、多糖类等成分。防风煎剂或醇浸剂,给兔灌胃或给大鼠腹腔注射,有解热作用;给小鼠灌胃或腹腔及皮下注射防风煎剂及醇浸剂,有镇痛作用;肌注正丁醇提取物,可降低大鼠血液黏度;防风煎剂、醇浸剂灌服或腹腔给药,对大鼠、小鼠具抗炎免疫作用。防风煎剂具抗菌、抗病毒作用。
菊花:性微寒,味甘、苦。归肺经、肝经。散风清热、平肝明目。属解表药下属分类的辛凉解表药。用治风热感冒、头痛眩晕、目赤肿痛、眼目昏花。含腺嘌呤、胆碱、水苏碱、密蒙花苷等。气虚胃寒,食少泄泻之病,宜少用之。凡阳虚或头痛而恶寒者均忌用。
常山:性寒,味苦、辛。有毒。归肺经、肝经、心经。截疟、涌吐劫痰。属涌吐药。用治痰饮停聚,胸膈痞塞,疟疾。含常山碱甲、常山碱乙和常山碱丙、常山次碱、喹唑酮、常山素A、常山素B和伞形花内酯等。总提取物对人工培养的恶性疟原虫和动物实验性疟原虫均有较好疗效。常山碱乙抗阿米巴原虫效力比依米丁大1倍。动物试验表明,常山碱甲、常山碱乙、常山碱丙能降低血压。佩兰:性平,味辛。归脾经、胃经、肺经。芳香化湿、醒脾开胃、发表解暑。属化湿药。多用治湿浊中阻、脘痞呕恶、口中甜腻、口臭、多涎、暑湿表症、头胀胸闷。含挥发油;叶含香豆精、香豆酸、麝香草氢醌;根含兰草素。对流行性感冒病毒有抑制作用;并能抑制排卵。
石苇:性微寒,味甘、苦。气微,味微涩苦。可以利尿通淋,清热止血。用在热淋、石淋、小便不利、淋沥涩痛、吐血、衄血、尿血、崩漏、肺热咳嗽等症状有不错的效果。
桑寄生:味苦、甘,性平。归肝经、肾经。补肝肾、强筋骨、祛风湿、安胎元。属祛风湿药下属分类的祛风湿强筋骨药。用治风湿痹痛、腰膝酸软、筋骨无力、崩漏经多、妊娠漏血、胎动不安、高血压。含黄酮类化合物,主要为广寄生苷、槲皮素及槲皮苷;叶中含金丝桃苷。桑寄生水浸出液、乙醇一水浸出液和30%乙醇浸出液均对麻醉动物有降压作用;注射液对正常和颤动的豚鼠心脏冠状血管有舒张作用。此外,还具利尿和抗病毒作用。
蛇床子:性温,味辛、苦。归肾经。温肾壮阳、燥湿、祛风、杀虫。属杀虫止痒药。具性激素样、平喘、镇静、局部麻醉和抗微生物等作用。含挥发油,主要成分为蒎稀、异缬草酸龙脑酯、欧芹酚甲醚、二氢欧山芹醇、佛手柑内酯、蛇床子素、异茴芹素等。
何首乌:性温,味苦、甘、涩。归肝经、肾经、心经。解毒、消痈、润肠通便。属补虚药下分类的补血药。何首乌具抗衰老、增强免疫、促进肾上腺皮质的功能。能促进血细胞新生和发育、调节血脂和抗动脉粥样硬化,并具保肝作用。用治瘰疬疮痈、风疹瘙痒、肠燥便秘、高血脂。含蒽醌类化合物,其中大黄素-8-O-B-D-葡萄糖苷是何首乌中促智的活性成分之一;醌类成分二苯乙烯苷2,3,5,4-四羟基二苯乙烯一2-O-B-D-葡萄糖苷具有广泛的心血管活性、免疫调节、保肝作用等,酰胺化合物有穆坪马兜酰胺、N-反式阿魏酰基-3-甲基多巴胺等;色原酮类有7一羟基.2,5.二甲基色原酮等;以二苯乙烯苷,为抗衰老、降血脂的活性成分。另含的2,3,5,4-四羟基二苯乙烯-2-O-(6”-O-a-D-吡喃葡萄糖)-B-D-葡萄糖苷具抑制血管平滑肌细胞增殖活性作用。
丁香:味辛,性温。归胃经、脾经、肾经。用治脾胃虚寒、呃逆呕吐、食少吐泻、心腹冷痛、肾虚阳痿。温中降逆、补肾助阳。具健胃作用,浸出液具有明显的刺激胃液分泌作用,并能缓解腹胀、恶心、呕吐等。另外,对多种致病性真菌、球菌、链球菌及肺炎、痢疾、大肠、伤寒等杆菌以及流感病毒有抑制作用。
苏木:性平,味甘、咸。归心经、肝经、脾经。行血祛瘀,消肿止痛。属活血化瘀药下属分类的活血止痛药。用治跌打损伤,骨折筋伤,瘀滞肿痛,经闭痛经,产后瘀阻,胸腹刺痛,痈疽肿痛。心材含色原烷类化合物。还含巴西苏木素(drazilin),3′-O-甲基巴西苏木素(3′-O-methylbrazilin)和巴西苏木素衍生物(brazilinderivatives)1及2。又含二苯并环氧庚烷类化合物、苏木苦素(calsalpin)J、P,二十八醇,β-谷甾醇及蒲公英赛醇。
决明子:性微寒,味苦、甘。归肝经、肾经、大肠经。清热明目、润肠通便。属清热药下分类的清虚热药。用治虚火上攻或肝经风热等所致目赤肿痛、羞明多泪以及夜盲症;热结便秘、肠燥便秘;肝阳上亢之头晕头痛等。含游离羟基蒽醌衍生物,为大黄酚、大黄素、大黄素甲醚、决明素、钝叶素、决明苷、钝新素等多种成分。可用HPLC法测定其大黄酚或决明子苷A的含量。其水浸液有降压、利尿作用,并有缓泻、收缩子宫作用;其醇浸出液对葡萄球菌及白喉、巨大芽孢、伤寒、副伤寒、乙型副伤寒、大肠等杆菌均有抑制作用;其水浸剂对多种致病性皮肤真菌均有抑制作用,并有降血脂的作用。
高良姜:性微寒,味苦、甘。归肝经、肾经、大肠经。清热明目、润肠通便。属清热药下分类的清虚热药。用治虚火上攻或肝经风热等所致目赤肿痛、羞明多泪以及夜盲症;热结便秘、肠燥便秘;肝阳上亢之头晕头痛等。含游离羟基蒽醌衍生物,为大黄酚、大黄素、大黄素甲醚、决明素、钝叶素、决明苷、钝新素等多种成分。可用HPLC法测定其大黄酚或决明子苷A的含量。其水浸液有降压、利尿作用,并有缓泻、收缩子宫作用;其醇浸出液对葡萄球菌及白喉、巨大芽孢、伤寒、副伤寒、乙型副伤寒、大肠等杆菌均有抑制作用;其水浸剂对多种致病性皮肤真菌均有抑制作用,并有降血脂的作用。
花椒:性温,味辛。归脾经、胃经、肾经。温中止痛、杀虫止痒。属温里药。用治脘腹冷痛、呕吐泄泻、虫积腹痛、蛔虫症等;外用治湿疹瘙瘁。含挥发油,油中含有柠檬烯、枯醇、牻牛儿醇等。药理实验表明,果皮注射液有止痛、麻醉作用;牻牛儿醇小量可引起离体肠管蠕动,大量则使之抑制;水煎剂对链球菌、葡萄球菌、肺炎球菌、炭疽杆菌、枯草杆菌、霍乱弧菌、副伤寒杆菌和绿脓杆菌均有抑制作用;所含挥发油可使蛔虫、蛲虫中毒。
大蓟:性凉,味甘、苦。归心经、肝经。凉血止血、祛瘀消肿。属止血药下属分类的凉血止血药。用治衄血、吐血、尿血、便血、崩漏下血、外伤出血、痈肿疮毒。鲜叶含有6-甲氧基柳穿鱼苷、6,4’一二甲氧基黄芩素-7-鼠李葡萄糖苷。并含柳穿鱼素,5,7-二羟基-6,4’一二甲氧基黄酮。据报道,全草显生物碱及挥发油反应。具有降血压、抗菌等作用,对脑膜炎球菌、白喉杆菌有抑制作用。
黄芪:性微温,味甘。归脾经、肺经。补气固表、利尿、托毒排脓、生肌。属补虚药下属分类的补气药。治疗气短心悸、乏力、虚脱、自汗、盗汗、体虚浮肿、慢性肾炎、久泻、脱肛、子宫脱垂、痈疽难溃、疮口久不愈合、小儿支气管哮喘、慢性乙型肝炎、慢性肾炎和病毒性心肌炎。补气宜炙用,止汗、利尿、托毒排脓生肌宜生用。
莪术:性温,味辛、苦。归脾经、肝经。行气破血、消积止痛。属于活血化瘀药下属的破血消癥药。用于治疗癥瘕痞块、瘀血经闭、食积胀痛、早期宫颈癌。含挥发油。临床用莪术油注射剂静脉滴注治疗血栓闭塞性脉管炎获较好疗效,对婴儿RSV肺炎有较好疗效且无副作用。油制剂具抗肿瘤作用,治疗卵巢癌、恶性淋巴癌、肺癌、肝癌有一定疗效。
本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,具有杀菌能力强,作用速度快,稳定性好的显著优点,对人无刺激,无毒副作用,是一种值得推广的理想的抗菌消炎药物。
(四)具体实施方式
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效。
实施例1:
取知母25克、连翘26克、大黄23克、大戟22克、芫花23克、丹皮21克、地丁23克、枇杷叶26克、茜草25克、艾叶24克、侧柏叶26克、茵陈25克、良姜23克、沉香22克、海藻23克、雄黄25克、麻黄22克、桂枝26克、防风25克、菊花23克、常山22克、佩兰22克、石苇23克、桑寄生22克、蛇床子25克、何首乌23克、丁香22克、苏木23克、决明子25克、高良姜-22克、花椒23克、大蓟24克、黄芪23克、莪术25克,使用时,取10g雾化吸入用药粉,加入50℃生理盐水或净水40ml摇匀,进行雾化面罩吸入。
实施例2:
取知母10克、连翘11克、大黄10克、大戟10克、芫花10克、丹皮10克、地丁10克、枇杷叶10克、茜草10克、艾叶10克、侧柏叶10克、茵陈10克、良姜10克、沉香10克、海藻10克、雄黄10克、麻黄10克、桂枝10克、防风10克、菊花10克、常山10克、佩兰10克、石苇10克、桑寄生10克、蛇床子10克、何首乌10克、丁香10克、苏木10克、决明子10克、高良姜10克、花椒10克、大蓟10克、黄芪10克、莪术10克,使用时,取10g雾化吸入用药粉,加入50℃生理盐水或净水40ml摇匀,进行雾化面罩吸入。
实施例3:
取知母20克、连翘21克、大黄17克、大戟16克、芫花17克、丹皮18克、地丁16克、枇杷叶21克、茜草20克、艾叶20克、侧柏叶21克、茵陈21克、良姜18克、沉香18克、海藻16克、雄黄20克、麻黄18克、桂枝19克、防风21克、菊花18克、常山18克、佩兰17克、石苇19克、桑寄生18克、蛇床子20克、何首乌16克、丁香17克、苏木18克、决明子21克、高良姜18克、花椒19克、大蓟19克、黄芪18克、莪术17克,使用时,取10g雾化吸入用药粉,加入50℃生理盐水或净水40ml摇匀,进行雾化面罩吸入。
临床实验:
1、实验菌种:肺炎双球菌、人型结核杆菌、百日咳杆菌。
2、菌种培养基:营养琼脂培养基和营养肉汤培养基。
3、抑菌实验分实验组和对照组,实验组为本发明杀菌药物,对照组选用氯酸钠消毒液。
4、具体实验步骤:
(1)制备菌液:将上述两组菌种分别接种于两个琼脂培养基上,在37℃下培养24小时,分别从中挑取典型菌落分别接种于两个新鲜的营养肉汤培养基中,同温度下,培养18小时,备用;
(2)分别取本发明药物和氯酸钠消毒液各100ml,分别置于稀释容器中,对其分别稀释20倍,将上两种稀释液溶液分别分置两个容器内,置于无菌条件下,备用;
(3)将上述步骤(1)经营养肉汤培养18小时的实验菌种用无菌的营养肉汤分别稀释100倍,每种菌种分装于两个培养皿中,分别标记对照组和实验组;
(4)将上述步骤(2)所得的本发明的稀释溶液滴入实验组培养皿,氯酸钠消毒液稀释溶液滴入对照组培养皿。
5、实验观察测量:
菌种 | 实验组 | 对照组 | 菌落残留面积 |
肺炎双球菌 | 2.5% | 25.9% | - |
人型结核杆菌 | 3.2% | 32% | - |
百日咳杆菌 | 1.3% | 27.3% | - |
对上述实验进行观察并测量菌种残留面积,具体结果如上表。
6、观测测量完毕后,将上述培养皿均置于无菌条件下静置三天,跟踪观察发现,对照组菌落继续繁殖,而实验组菌落无变化。
7、实验结果:
实验组的杀菌能力远大于对照组的杀菌能力,且能够抑制菌种继续繁殖。
Claims (3)
1.一种治疗呼吸道感染的雾化吸入液中药制剂,其特征为,制成所述药物有效成分的原料组成及重量份数为:知母10-25克、连翘11-26克、大黄10-23克、大戟10-22克、芫花10-23克、丹皮10-21克、地丁10-23克、枇杷叶10-26克、茜草10-25克、艾叶10-24克、侧柏叶10-26克、茵陈10-25克、良姜10-23克、沉香10-22克、海藻10-23克、雄黄10-25克、麻黄10-22克、桂枝10-26克、防风10-25克、菊花10-23克、常山10-22克、佩兰10-22克、石苇10-23克、桑寄生10-22克、蛇床子10-25克、何首乌10-23克、丁香10-22克、苏木10-23克、决明子10-25克、高良姜10-22克、花椒10-23克、大蓟10-24克、黄芪10-23克、莪术10-25克。
2.根据权利要求1所述的一种治疗呼吸道感染的雾化吸入液中药制剂,其特征为,制成所述药物有效成分的原料组成及重量份数为:知母10克、连翘11克、大黄10克、大戟10克、芫花10克、丹皮10克、地丁10克、枇杷叶10克、茜草10克、艾叶10克、侧柏叶10克、茵陈10克、良姜10克、沉香10克、海藻10克、雄黄10克、麻黄10克、桂枝10克、防风10克、菊花10克、常山10克、佩兰10克、石苇10克、桑寄生10克、蛇床子10克、何首乌10克、丁香10克、苏木10克、决明子10克、高良姜10克、花椒10克、大蓟10克、黄芪10克、莪术10克。
3.根据权利要求1或2所述的治一种治疗呼吸道感染的雾化吸入液中药制剂,其特征在于:还包含以下制作步骤:
(1)将莪术、大蓟、高良姜、何首乌、桂枝以水蒸气蒸馏提取挥发油,并收集药渣混合备用;
(2)将余药和步骤1中所得药渣混匀加5倍水量,加水煎煮2次,每次50min,合并煎液,静置;然后往煎液中加入3~4倍药液的95%的乙醇,静置15分钟,然后以3000rpm/min离心20分钟,取上清液,喷雾干燥,得出初料;
(3)将步骤1中所得挥发油喷入步骤2所得初料中,混匀,粉碎,过100目筛,密封、灭菌处理,贴签,分装而成。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510926231.XA CN105477541A (zh) | 2015-12-15 | 2015-12-15 | 一种治疗呼吸道感染的雾化吸入液中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510926231.XA CN105477541A (zh) | 2015-12-15 | 2015-12-15 | 一种治疗呼吸道感染的雾化吸入液中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105477541A true CN105477541A (zh) | 2016-04-13 |
Family
ID=55665049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510926231.XA Pending CN105477541A (zh) | 2015-12-15 | 2015-12-15 | 一种治疗呼吸道感染的雾化吸入液中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105477541A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104488986A (zh) * | 2014-12-26 | 2015-04-08 | 孔祥华 | 一种检验科用中药杀菌液 |
-
2015
- 2015-12-15 CN CN201510926231.XA patent/CN105477541A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104488986A (zh) * | 2014-12-26 | 2015-04-08 | 孔祥华 | 一种检验科用中药杀菌液 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104799115A (zh) | 一种鸡配合饲料及其制备方法 | |
CN103933509B (zh) | 用于治疗淡水鱼水霉病的药物及其制备方法 | |
CN106804643A (zh) | 一种检验科用中药杀菌消毒液 | |
CN102600417B (zh) | 一种治疗牛羊瘤胃鼓气的中药组合物 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN103920027A (zh) | 用于治疗急性黄疸型乙型肝炎的药物及其制备方法 | |
CN106266885A (zh) | 一种检验科用中药消毒液 | |
CN103041262B (zh) | 一种治疗慢性前列腺炎的中药灌肠剂及其制备方法 | |
CN105326908A (zh) | 一种治疗鼻炎的药物组合物及其用途 | |
CN105056159A (zh) | 一种治疗猪寄生虫病的药物及其制备方法 | |
CN104840695A (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
CN103656048B (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN103893737A (zh) | 用于治疗支气管哮喘的药物及其制备方法 | |
CN104906502A (zh) | 一种用于治疗鸡伤热的药物组合物及其制备方法 | |
CN104887950A (zh) | 一种治疗乳痈的中药组合物 | |
CN104623615A (zh) | 一种治疗哮喘的药物 | |
CN104491709A (zh) | 一种用于治疗牛尿路结石的药物组合物及其制备方法 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN105477541A (zh) | 一种治疗呼吸道感染的雾化吸入液中药制剂 | |
CN104435244A (zh) | 一种有效治疗乳岩的中药组合物 | |
CN102940760B (zh) | 一种防治猪瘟的中药组合物 | |
CN103690771B (zh) | 用于治疗羔羊大肠杆菌病的药物及其制备方法 | |
CN102755467B (zh) | 一种治疗冻伤的罗沙冬油膏及其制备方法 | |
CN105963586A (zh) | 一种治疗肺脓肿的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160413 |
|
WD01 | Invention patent application deemed withdrawn after publication |